亚临床甲状腺功能障碍和痴呆的风险:一个元分析
Qiao Liu1, Chaoyin Lu1, Mengdie Chen1
1Department of Endocrinology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.
Brain and behavior
|September 19, 2024
概括
患有亚临床甲状腺功能障碍的人面临痴呆症的风险增加. 这种状况的特征是甲状腺激素水平异常,与一般人群中痴呆发病率较高有关.
科学领域:
- 内分泌学 在内分泌学.
- 神经学 神经学
- 老年学是一门学科.
背景情况:
- 甲状腺功能障碍越来越多地与痴呆风险有关.
- 之前关于亚临床甲状腺功能障碍和痴呆风险的研究产生了不一致的结果.
- 这项研究解决了对这种关联进行全面评估的需要.
研究的目的:
- 系统地审查和元分析现有的队列研究.
- 评估亚临床甲状腺功能障碍症和一般人口中痴呆发病率之间的关系.
主要方法:
- 搜索了PubMed,科学网和Embase的相关队列研究.
- 采用随机效应模型来组合数据并考虑异质性.
- 进行子组和元回归分析以探索异质性来源.
主要成果:
- 包括9个队列研究,49,218名参与者;6.5%患有亚临床甲状腺功能障碍.
- 随访发现了4044例痴呆病例,平均时间为10.2年.
- 亚临床甲状腺功能障碍与更高的痴呆发病率有关 (RR: 1.38,95% CI: 1.09-1.74).
- 超回归表明TSH切断显著影响了相关性,并解释了异质性.
结论:
- 亚临床甲状腺功能障碍症可能会增加痴呆症的风险,与甲状腺功能障碍症相比.
- 这些发现凸显了甲状腺功能障碍对神经系统的潜在影响.
相关概念视频
Dementia
102
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
102
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Psychoneuroimmunology: Diabetes and Cancer
25
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
25
Cognitive Development During Adulthood
66
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
66


